Changes

1 byte added ,  01:36, January 8, 2008
Correcting cost/benefit analysis which was based on a faulty statistic.
Line 15: Line 15:  
Merck manufactures the HPV vaccine ("Gardasil") and sells it for $360 ($120 per shot in a three-shot series).  Its package insert explains the limitations of the vaccine and describes its testing for safety and efficacy.<ref>http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf</ref>
 
Merck manufactures the HPV vaccine ("Gardasil") and sells it for $360 ($120 per shot in a three-shot series).  Its package insert explains the limitations of the vaccine and describes its testing for safety and efficacy.<ref>http://www.merck.com/product/usa/pi_circulars/g/gardasil/gardasil_pi.pdf</ref>
   −
The cost for buying and administering the three-dose vaccine is about $500 per child. Accordingly, the cost of vaccinating 100 children will be about $50,000, but only 3 out of that 100 will ever be exposed to the HPV types targeted by the vaccine.{{fact}} The average age of diagnosis of cervical cancer is 48 years old. Accordingly, the cost is $15,000 to $50,000 per child to possibly protect her against a cancer over 30 years in the future. There is not yet a clear plan in place for funding this vaccine. Despite the high cost and low prevalance, many states have pending legislation that would require schoolgirls to receive the vaccine.<ref>http://www.ncsl.org/programs/health/HPVvaccine.htm</ref>
+
The cost for buying and administering the three-dose vaccine is about $500 per child. Accordingly, the cost of vaccinating 100 children will be about $50,000, but only 27 out of that 100 will ever be exposed to the HPV types targeted by the vaccine.{{fact}} The average age of diagnosis of cervical cancer is 48 years old. Accordingly, the cost is $15,000 to $50,000 per child to possibly protect her against a cancer over 30 years in the future. There is not yet a clear plan in place for funding this vaccine. Despite the high cost and low prevalance, many states have pending legislation that would require schoolgirls to receive the vaccine.<ref>http://www.ncsl.org/programs/health/HPVvaccine.htm</ref>
    
Alternative means of protection against cervical cancer include abstinence (most effective), and early detection via pap smear (effective if done regularly, but only ''detects'' infection or precancerous changes.  It does not ''prevent'' infection, but can prevent progression from infection to cancer). <ref>http://www.cdc.gov/std/HPV/STDFact-HPV.htm#cancer</ref>. Condoms are not a safeguard against  infection<ref>http://content.nejm.org/cgi/content/full/354/25/2645</ref> <ref> Report to Congress 2004: Prevention of Genital Human Papillomavirus Infection, Centers for Disease Control and Prevention, Gerberding, J.L., M.D., M.P.H. (January 2004): pp. 3-4. </ref>
 
Alternative means of protection against cervical cancer include abstinence (most effective), and early detection via pap smear (effective if done regularly, but only ''detects'' infection or precancerous changes.  It does not ''prevent'' infection, but can prevent progression from infection to cancer). <ref>http://www.cdc.gov/std/HPV/STDFact-HPV.htm#cancer</ref>. Condoms are not a safeguard against  infection<ref>http://content.nejm.org/cgi/content/full/354/25/2645</ref> <ref> Report to Congress 2004: Prevention of Genital Human Papillomavirus Infection, Centers for Disease Control and Prevention, Gerberding, J.L., M.D., M.P.H. (January 2004): pp. 3-4. </ref>
nsTeam1RO, nsTeam1RW, nsTeam1_talkRO, nsTeam1_talkRW
675

edits